simulect 20 mg
novartis pharmaceutica s.a. - spania - basiliximabum - pulb. pt. sol. inj. sau perf. - 20mg - imunosupresoare inhibitori de interleukina
simulect 20 mg
novartis pharmaceutica s.a. - spania - basiliximabum - pulb.+solv. pt. sol. inj. sau perf. - 20mg - imunosupresoare inhibitori de interleukina
temozolomida hf 5 mg
nerpharma s.r.l. - italia - temozolomidum - caps. - 5mg - agenti alchilanti alti agenti alchilanti
temozolomida hf 20 mg
nerpharma s.r.l. - italia - temozolomidum - caps. - 20mg - agenti alchilanti alti agenti alchilanti
temozolomida hf 100 mg
nerpharma s.r.l. - italia - temozolomidum - caps. - 100mg - agenti alchilanti alti agenti alchilanti
temozolomida hf 140 mg
nerpharma s.r.l. - italia - temozolomidum - caps. - 140mg - agenti alchilanti alti agenti alchilanti
temozolomida hf 180 mg
nerpharma s.r.l. - italia - temozolomidum - caps. - 180mg - agenti alchilanti alti agenti alchilanti
temozolomida hf 250 mg
nerpharma s.r.l. - italia - temozolomidum - caps. - 250mg - agenti alchilanti alti agenti alchilanti
everio 25 micrograme/125 micrograme/doza
genetic s.p.a. - italia - salmeterolum+fluticasonum - susp. de inhalat presurizata - 25micrograme/125micrograme/doza - adrenergice inhalante adrenergice si alte med. pt. trat. bolilor obstructive c.r
everio 25 micrograme/250 micrograme/doza
genetic s.p.a. - italia - salmeterolum+fluticasonum - susp. de inhalat presurizata - 25micrograme/250micrograme/doza - adrenergice inhalante adrenergice si alte med. pt. trat. bolilor obstructive c.r